Afya (AFYA) Investor Day 2024 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2024 summary
18 Jan, 2026Strategic vision and business model
Focused exclusively on medical education and digital solutions, providing a unified ecosystem supporting physicians from undergraduate to daily practice, with a strong reputation and high NPS among users.
Integrated approach combines organic growth and acquisitions, resulting in fourfold operational growth since IPO and national leadership in medical education.
Robust partnerships with over 500 hospitals and clinics, and strong engagement with the pharmaceutical industry, driving value for students and industry partners.
Brand awareness initiatives and events like Afya Summit have significantly increased recognition among medical professionals, with brand awareness rising from 31% to 54% in one year.
Operates 32 medical school campuses and 5 multidisciplinary campuses, holding an 11% market share among private schools in Brazil.
Educational excellence and ecosystem
Over 22,000 medical students enrolled across 32 units in 14 states, with more than 20,000 physicians trained since 1999.
Commitment to continuous education, with 40,000+ students in postgraduate and continuing education programs and 250,000+ monthly active users on digital platforms.
Curriculum is nationally standardized, emphasizing early and continuous practical experience, evidence-based training, and regular progress assessments.
Simulation centers accredited by international bodies and integration of digital tools like Whitebook throughout the academic journey.
High regulatory scores (96% of students rated 4 or 5) and strong student performance, especially after curriculum integration post-acquisitions.
Digital solutions and innovation
Whitebook is the leading clinical decision support tool, impacting 55 million consultations annually and integrating features like digital prescription and AI-driven epidemiological insights.
iClinic and other management tools automate office routines, enhance patient care, and introduce AI features such as Smart Clinic AI for transcription and summarization.
Patient-focused digital assets (GLIC, Cliquefarma, agendaconsulta.com) support chronic disease management, medication access, and appointment scheduling, with plans to unify these into a single patient portal.
B2B partnerships with pharmaceutical companies leverage the ecosystem for targeted campaigns, insights, and engagement, with 47 unique clients and 109 contracts in 2024.
The Whitebook app, now integrated with iClinic RX, supports over 21 million medical content searches monthly and 1 million prescriptions per month.
Latest events from Afya
- Double-digit growth in revenue, profit, and cash flow, with strong 2026 outlook and capital discipline.AFYA
Q4 202513 Mar 2026 - Double-digit growth, margin gains, and raised 2024 guidance driven by organic and acquisition-led expansion.AFYA
Q2 20242 Feb 2026 - Net revenue and EBITDA rose over 16% and 25% YoY, with strong cash flow and margin gains.AFYA
Q3 202414 Jan 2026 - Integrated education, technology, and clinical practice drive growth, innovation, and strong 2025 guidance.AFYA
Investor Day 202529 Dec 2025 - Double-digit growth, margin expansion, and strong cash flow with disciplined capital management.AFYA
Q3 202526 Dec 2025 - Net income up 60.1%, margin at 44.1%, and 2025 guidance signals further growth.AFYA
Q4 202425 Dec 2025 - Record EBITDA margin, strong cash flow, and market leadership marked the robust 1Q25 results.AFYA
Q1 202526 Nov 2025 - Double-digit revenue and EBITDA growth, margin gains, and buyback plans amid tax changes.AFYA
Q2 202523 Nov 2025